London, UK-based venture capital firm Dawn Capital has closed its new Opportunities Fund, at $125m.
Dedicated to funding later stage, high-growth businesses, the fund is backed by institutional and family office investors across Europe and the US, including British Patient Capital, which committed £48.8m.
The new fund will enable Dawn to invest up to $70m in European entrepreneurs that are solving the greatest tech challenges facing businesses with scalable, game-changing technology. The vehicle will see the the firm double down on investments in the most promising companies in European tech in their portfolio and elsewhere, with a specific focus on C-rounds and beyond. In addition, Dawn will also be looking to invest in other high-performing late-stage European tech companies to expand its portfolio.
Led by Haakon Overli, General Partner, Dawn Capital is a VC firm dedicated to B2B software and B2B fintech startups across Europe.
The firm is currently investing out of its third fund of $235m. The portfolio companies include Mimecast (NASDAQ: MIME with $2.7 market cap), iZettle (sold to PayPal for $2.2BN cash), Collibra, Showpad, Dataiku, Templafy, Quantexa and Garrison, with others.